News from ampio pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 17, 2015, 11:30 ET

Ampio Hosts Investor Call to Discuss Updates on Ampion™ and Optina™

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) held a conference call on Thursday, July 16, 2015 to discuss updates on its two...

Jul 09, 2015, 12:10 ET

Ampio Announces Investor Call on Thursday, July 16, 4:30 p.m. EDT

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced dial-in details for a scheduled investor call to discuss updates on its two...

Jun 22, 2015, 08:30 ET

Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina™ in the Treatment of Diabetic Macular Edema (DME)

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that further data analysis from the 12-week multi-center, placebo-controlled,...

Jun 16, 2015, 08:30 ET

Ampio Pharmaceuticals Provides Information on the Formation and Significance of Aytu BioScience to Ampio Shareholders

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today provided shareholders information on the formation and recent activities of Aytu...

Jun 09, 2015, 08:30 ET

Ampio Pharmaceuticals Reports the Synergistic Effects of Ampion™ in the Treatment of Osteoarthritis of the Knee in Three Peer-reviewed Publications

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced three peer-review publications that report the multifaceted and synergistic effects of...

Jun 04, 2015, 08:00 ET

Ampio Pharmaceuticals Announces Update of STRIDE Study for the Investigation of Pain Associated with Osteoarthritis

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced week 20 and week 24 results of the STRIDE study, a phase III clinical trial to...

May 21, 2015, 08:00 ET

Ampio Pharmaceuticals Announces Positive Study Results on Optina™ for the Treatment of Diabetic Macular Edema

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced positive results of the OptimEyes trial for DME. The OptimEyes trial was a...

Apr 21, 2015, 08:30 ET

Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced dial-in details for a scheduled investor call on Thursday, April 23, 4:30 p.m. ET....

Apr 20, 2015, 08:45 ET
Ampio Pharmaceuticals Logo.

AMPIO Announces Ampion™ STRIDE Study Results

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the multiple injection STRIDE study AP008 did not reach its primary endpoint...

Feb 25, 2015, 07:03 ET
http://photos.prnewswire.com/medias/switch.do?prefix=/appnb&page=/getStoryRemapDetails.do&prnid=20120516%252fMM09116LOGO&action=details

Ampio Announces Top-Line Results of the Double-Blind Multiple Intra-Articular Injections (STRUT) Study of Ampion™ in Patients with Moderate to Severe Osteoarthritis of the Knee

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced results of the double-blind, multiple injection, vehicle controlled STRUT study...

Feb 20, 2015, 16:30 ET
Ampio Pharmaceuticals Logo.

Ampio Pharmaceuticals to present at the International Society for Pharmaceutical Engineers (ISPE) 24th Annual Aseptic Processing Technology Conference on February 23rd, 2015

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present on single use technology in...

Jan 08, 2015, 07:57 ET
Ampio Pharmaceuticals Logo.

Vyrix Pharmaceuticals to Present at Biotech Showcase™ 2015

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that its wholly-owned subsidiary Vyrix Pharmaceuticals, Inc. is scheduled to present...

Dec 04, 2014, 08:00 ET
Ampio Pharmaceuticals Logo

Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present a corporate update at the 25th Annual...

Dec 01, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.

Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twenty of the Trial

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced updates for the STRUT open label portion (n=7) of the multiple injection study...

Nov 24, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.

Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress

Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced the presentation of three clinical and...

Nov 12, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.

Ampio updates status of clinical trials and manufacturing facility

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced an update on its ongoing clinical trials. Dr, Vaughan Clift, Ampio's Chief...

Oct 16, 2014, 16:02 ET
Ampio Pharmaceuticals Logo.

Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the Trial

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced updates for the STRUT and STRIDE multiple injection studies that are proceeding...

Sep 15, 2014, 14:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) a clinical trial stage biopharmaceutical company primarily focused on the development of therapies...

Sep 02, 2014, 07:56 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Update on the Phase III multicenter, double-blind STEP study of Ampion™ for Osteoarthritis of the Knee

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™...

Aug 25, 2014, 07:56 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is issuing this response to the most commonly asked questions in regards to the STEP study...